Evidence map›Paper›PMID 16583175›Full record

ReviewHeart failure reviews2005

Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.

William C Stanley, Hani N Sabbah

Abstract readReview
PubMed Publisher
In one paragraph

Review in Heart failure reviews, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Mechanism ofFrontiers in nutrition · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mitochondria and cardioprotection.Heart failure reviews · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

William C StanleyDepartment of Physiology and Biophysics, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44122, USA. WCS4@case.edu
Hani N Sabbah
Case Western Reserve University · USHenry Ford Health System · US

Funding

Substrate Selection and Oxidative Stress in Heart FailureP01HL074237 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI STANLEY, WILLIAM C · 2003 to 2013
$19.9M
NHLBI NIH HHS P01 HL074237-03
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carbohydrate MetabolismClinical Trials as TopicEnergy MetabolismFatty AcidsHumansMyocardial IschemiaOxidation-ReductionTrimetazidineVasodilator AgentsFatty AcidsTrimetazidineVasodilator Agents

Identifiers

PMID16583175
OpenAlexW1987544502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.